Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Medtronic
McKesson
AstraZeneca
Boehringer Ingelheim
Colorcon

Last Updated: November 30, 2021

DrugPatentWatch Database Preview

Patent: 9,775,946

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 9,775,946
Title:Unified drug mixer and dispenser
Abstract: A unified dispenser for holding, mixing, and dispensing a drug includes a housing holding a diluent reservoir, a drug reservoir, and a tubing set connecting and defining a fluid communication path therebetween. A first occlusion is at the diluent reservoir, and a second occlusion is at the drug reservoir. In a storage state of the dispenser, the first and second occlusions are entirely encased within the housing and occlude the fluid communication path. First and second pull assemblies extend outside the housing. The first and second pull assemblies are coupled to the first and second occlusions, respectively, so that removal of the first and second pull assemblies removes the first and second occlusions and joins the diluent reservoir to the drug reservoir in fluid communication through the tubing set, thereby arranging the dispenser from the storage state to a use state.
Inventor(s): McNall, III; Ralph I. (Belmont, CA), Donze; Thomas T. (South San Francisco, CA), MacDonell; Andrew M. (San Francisco, CA), Joshi; Serena (San Francisco, CA)
Assignee:
Application Number:15/041,157
Patent Claims:see list of patent claims

Details for Patent 9,775,946

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Pfizer Inc. ELELYSO taliglucerase alfa For Injection 022458 2012-05-01 ⤷  Free Forever Trial 2039-02-26
Shire Human Genetic Therapies, Inc. VPRIV velaglucerase alfa For Injection 022575 2010-02-26 ⤷  Free Forever Trial 2039-02-26
Takeda Pharmaceuticals U.s.a., Inc. VPRIV velaglucerase alfa For Injection 022575 2010-02-26 ⤷  Free Forever Trial 2039-02-26
Recordati Rare Diseases, Inc. PANHEMATIN hemin for injection For Injection 101246 1983-07-20 ⤷  Free Forever Trial 2039-02-26
Amgen, Inc. NEUPOGEN filgrastim Injection 103353 1991-02-20 ⤷  Free Forever Trial 2039-02-26
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Boehringer Ingelheim
Medtronic
AstraZeneca
Harvard Business School
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.